LPCN Awaits FDA Panel Vote Today, APHB Slumps, BGNE Crosses $100 Again

Today's Daily Dose brings you news about the release of FDA's briefing document related to Aradigm's investigational drug Linhaliq; AmpliPhi's stock offering; Halozyme's rosy outlook on royalty revenue growth and Tandem Diabetes' preliminary Q4 results.

from RTT - Biotech http://ift.tt/2Fmzzyg
via IFTTT